Today, we announced the dosing of the first patient in REKINDLE, our Ph 2 clinical trial evaluating RE104 for the treatment of adjustment disorder (AjD) in patients with cancer and other serious medical conditions.
Read the release: bit.ly/3KsOU6M
#psychedelictherapeutics #adjustmentdisorder
Read the release: bit.ly/3KsOU6M
#psychedelictherapeutics #adjustmentdisorder
September 30, 2025 at 12:06 PM
Today, we announced the dosing of the first patient in REKINDLE, our Ph 2 clinical trial evaluating RE104 for the treatment of adjustment disorder (AjD) in patients with cancer and other serious medical conditions.
Read the release: bit.ly/3KsOU6M
#psychedelictherapeutics #adjustmentdisorder
Read the release: bit.ly/3KsOU6M
#psychedelictherapeutics #adjustmentdisorder
Psychedelic Therapeutics Market 2026-2034 | Size, Share & Trends
Source: divyasawant02.blogspot.com/2026/07/psyc...
#PsychedelicTherapeutics #MentalHealth #BehavioralHealth #DepressionTreatment #PTSDTreatment
Source: divyasawant02.blogspot.com/2026/07/psyc...
#PsychedelicTherapeutics #MentalHealth #BehavioralHealth #DepressionTreatment #PTSDTreatment
Psychedelic Therapeutics Market Size to Reach US$ 11.85 Billion by 2034: Growth Factors Explained
The Psychedelic Therapeutics is emerging as one of the most promising segments within the global pharmaceutical and mental healthcare indus...
divyasawant02.blogspot.com
July 3, 2026 at 12:37 PM
Psychedelic Therapeutics Market 2026-2034 | Size, Share & Trends
Source: divyasawant02.blogspot.com/2026/07/psyc...
#PsychedelicTherapeutics #MentalHealth #BehavioralHealth #DepressionTreatment #PTSDTreatment
Source: divyasawant02.blogspot.com/2026/07/psyc...
#PsychedelicTherapeutics #MentalHealth #BehavioralHealth #DepressionTreatment #PTSDTreatment